Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis

Abstract The prognosis of advanced biliary tract cancer remains poor despite up to 40% of tumors harboring actionable molecular alterations. This international collaborative study from Mayo Clinic, Duke Cancer Institute, National Cancer Center East (Japan), and the SCRUM-Japan GOZILA/MONSTAR-SCREEN...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Binbin Zheng-Lin, Taro Shibuki, Heidi E. Kosiorek, Oluseyi Abidoye, Cody R. Eslinger, Yasuyuki Kawamoto, Ryne C. Ramaker, Shinji Itoh, Tadayoshi Hashimoto, Takao Fujisawa, Mitsuho Imai, Angelo Pirozzi, Celine Hoyek, Mohamad B. Sonbol, Christina Wu, Nguyen H. Tran, Hani Babiker, Lewis R. Roberts, Ashley N. Moyer, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Makoto Ueno, Chigusa Morizane, Daniel H. Ahn, Madhuri Gottam, Mitesh J. Borad, John H. Strickler, Masafumi Ikeda, Tanios Bekaii-Saab
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2026-05-01
Colecção:	npj Precision Oncology
Acesso em linha:	https://doi.org/10.1038/s41698-026-01457-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!